Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Agustín Oterino"'
Autor:
Victor Obach, Fernando Velasco, Rocio Alvarez Escudero, María Martín Bujanda, Sonsoles Aranceta, Neus Fabregat, Teresa Marco, Aintzine Ruisanchez, Natalia Roncero, Ane Mínguez-Olaondo, Marta Ruibal, Daniel Guisado-Alonso, Antia Moreira, Elisa Cuadrado-Godia, Amaya Echeverria, Izaro Kortazar Zubizarreta, Alba López-Bravo, Nuria Riesco, Lucia González-Fernández, Nuria Pola, Paula Manera, Ángel Luis Guerrero-Peral, Agustín Oterino Duran, Yésica González-Osorio, Rosario Armand, Santiago Fernández-Fernández, David García-Azorín, Juan Carlos García-Moncó
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background Galcanezumab has shown efficacy and effectiveness in the treatment of episodic and chronic migraine (CM), however, the population represented in randomized clinical trials (RCTs) differs from the population observed in real-world
Externí odkaz:
https://doaj.org/article/b004166f59b241048d489a487c035582
Autor:
José E. Meca-Lallana, José M. Prieto González, Ana B. Caminero Rodríguez, Javier Olascoaga Urtaza, Ana M. Alonso, Eduardo Durán Ferreras, Raúl Espinosa, Julio Dotor, Mercedes Romera, Adrián Ares Luque, Domingo Pérez Ruiz, Carmen Calles, Miguel A. Hernández, Miguel Hervás García, Amelia Mendoza Rodríguez, Yasmina Berdei Montero, Nieves Téllez, Nicolás Herrera Varó, Javier Sotoca, Silvia Presas-Rodríguez, Luis A. Querol Gutierrez, Mariona Hervás Pujol, Jordi Batlle Nadal, Gisela Martín Ozaeta, Laura Gubieras Lillo, Sergio Martínez Yélamos, Lluís Ramió-Torrentà, Javier Mallada Frechin, Antonio Belenguer Benavides, Francisco Gascón-Giménez, Bonaventura Casanova, Lamberto Landete Pascual, Leticia Berenguer, Laura Navarro, Montserrat Gómez Gutierrez, Carmen Durán, Ana Rodríguez Regal, Elena Álvarez, Daniel A. García-Estévez, Ana M. López Real, Miguel A. Llaneza González, María E. Marzo Sola, José L. Sánchez-Menoyo, Agustín Oterino, Ramón Villaverde González, Tamara Castillo-Triviño, Amaya Álvarez de Arcaya, Cristina Llarena
Publikováno v:
Neurology and Therapy, Vol 12, Iss 6, Pp 2177-2193 (2023)
Abstract Introduction Teriflunomide is a once-daily oral immunomodulator approved for relapsing forms of multiple sclerosis (MS) or relapsing–remitting multiple sclerosis (RRMS; depending on the local label), based on extensive evidence from clinic
Externí odkaz:
https://doaj.org/article/0d5e12714aa14ddbb6e6eadf49cbbed1
Autor:
Robert Belvís, Pablo Irimia, Patricia Pozo-Rosich, Carmen González-Oria, Antonio Cano, Javier Viguera, Belén Sánchez, Francisco Molina, Isabel Beltrán, Agustín Oterino, Elisa Cuadrado, Angel Gómez-Camello, Miguel Alberte-Woodward, Carmen Jurado, Teresa Oms, David Ezpeleta, Javier Díaz de Terán, Noemí Morollón, Germán Latorre, Marta Torres-Ferrús, Alicia Alpuente, Raquel Lamas, Carlos Toledano, Rogelio Leira, Sonia Santos, Margarita Sánchez del Río
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Erenumab was approved in Europe for migraine prevention in patients with ≥ 4 monthly migraine days (MMDs). In Spain, Novartis started a personalized managed access program, which allowed free access to erenumab before official r
Externí odkaz:
https://doaj.org/article/fcecd02650084384bd50ba7605c09f88
Autor:
Inmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, Rafael Arroyo, Harald Hegen, Florian Deisenhammer, Susana Sainz de la Maza, José C. Alvarez-Cermeño, Guillermo Izquierdo, Dolores Paramo, Pedro Oliva, Bonaventura Casanova, Eduardo Agüera-Morales, Diego Franciotta, Matteo Gastaldi, Oscar Fernández, Patricia Urbaneja, José M. Garcia-Dominguez, Fernando Romero, Alicia Laroni, Antonio Uccelli, Angel Perez-Sempere, Albert Saiz, Yolanda Blanco, Daniela Galimberti, Elio Scarpini, Carmen Espejo, Xavier Montalban, Ludwig Rasche, Friedemann Paul, Inés González, Elena Álvarez, Cristina Ramo, Ana B. Caminero, Yolanda Aladro, Carmen Calles, Pablo Eguía, Antonio Belenguer-Benavides, Lluis Ramió-Torrentà, Ester Quintana, José E. Martínez-Rodríguez, Agustín Oterino, Carlos López de Silanes, Luis I. Casanova, Lamberto Landete, Jette Frederiksen, Gabriel Bsteh, Patricia Mulero, Manuel Comabella, Miguel A. Hernández, Mercedes Espiño, José M. Prieto, Domingo Pérez, María Otano, Francisco Padilla, Juan A. García-Merino, Laura Navarro, Alfonso Muriel, Lucienne Costa Frossard, Luisa M. Villar
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Overview: We assessed the role of age and disease activity as new factors contributing to establish the risk of progressive multifocal leucoencephalopathy in multiple sclerosis patients treated with natalizumab in 36 University Hospitals in Europe. W
Externí odkaz:
https://doaj.org/article/c82f6fa684d240fe86a6b469a1788aa1
Publikováno v:
Cephalalgia Reports, Vol 3 (2020)
Background: Methylation of two CpG sites related to neuronal pentraxin II protein (NPTX2) and SH2 domain containing 5 protein (SH2D5), corresponding to two neuroplasticity genes, has been associated to headache chronification. We aimed to investigate
Externí odkaz:
https://doaj.org/article/e13ba7ab3f0047a5b31c94b3dc4b6256
Autor:
Agustín Oterino Durán, Julio Pascual
Publikováno v:
Acta Neurológica Colombiana, Vol 24, Iss 3 supl 1 (2008)
Es evidente que la migraña se presenta con mayor frecuencia en algunos grupos familiares. Su transmisión genética no sigue un comportamiento acorde con las leyes de la herencia mendeliana; en ella intervienen múltiples factores, que son modulados
Externí odkaz:
https://doaj.org/article/c0ec5a44fe134b10937ae97a93380c90
Autor:
M.C. Fariñas, Manuel Gutiérrez-Cuadra, José Antonio Parra, Vicente González-Quintanilla, E. Palacios, Concepción Fariñas-Álvarez, Agustín Oterino, F. Arnaiz de las Revillas, Claudia González-Rico, Carlos Armiñanzas
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientifc Reports (2021) 11:18431
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Scientific Reports
Scientifc Reports (2021) 11:18431
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
The aim of this study was to analyse the association between human immunodeficiency virus (HIV) related clinical and analytical parameters and the presence of subclinical atherosclerosis as well as endothelial dysfunction. This was a prospective coho
Autor:
Agustín Oterino, C. Bailón, F. Hoyuela, O. Umaran Alfageme, Sara Pérez-Pereda, Vicente González-Quintanilla, M. Toriello
Publikováno v:
Neurología.
Resumen Introduccion El trastorno por estres postraumatico (TEPT) se ha postulado como un factor de cronificacion de la migrana. Nuestro objetivo fue investigar la frecuencia del TEPT y los eventos vitales traumaticos (ET) en pacientes con migrana ep
Autor:
María Carmen Fariñas, Concepción Fariñas-Álvarez, Manuel Gutiérrez-Cuadra, Vicente González-Quintanilla, Carlos Armiñanzas, Claudia González-Rico, Agustín Oterino, Francisco Arnaiz de las Revillas, Enrique Palacio, José Antonio Parra
Introduction: To analyze the association between human immunodeficiency virus (HIV) infection, and the presence of subclinical atherosclerosis and endothelial dysfunction. Methods Prospective cohort study of HIV positive patients who underwent to int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5e0e4541580184fc46de9f2b1b03848
https://doi.org/10.21203/rs.3.rs-259367/v1
https://doi.org/10.21203/rs.3.rs-259367/v1
Autor:
Agustín Oterino, C. González-Oria, Rogelio Leira, Pablo Irimia, Carlos Toledano, Belén Tabernero Sánchez, Francisco Molina, Carmen Jurado, Antonio Cano, Sonia Santos-Lasaosa, Robert Belvís, Javier Díaz de Terán, Miguel Alberte-Woodward, Marta Torres-Ferrus, Patricia Pozo-Rosich, Margarita Sanchez del Rio, G. Latorre, Teresa Oms, D. Ezpeleta, Raquel Lamas, Elisa Cuadrado, Alicia Alpuente, Isabel Beltran, Javier Viguera, Angel Gómez-Camello, Noemi Morollón
Background Erenumab was approved in Europe for migraine prevention in patients with ≥4 monthly migraine days (MMD). In Spain, Novartis started a personalized managed access program which allowed free access to erenumab before official reimbursement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5c009d9f0334fd818d3fd473688b97a
https://doi.org/10.21203/rs.3.rs-268641/v1
https://doi.org/10.21203/rs.3.rs-268641/v1